Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID MICHAEL CYPCAR

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1508857319
CMS profile
113905
Location
ASHEVILLE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$6,086.32

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID MICHAEL CYPCAR

NPI 1508857319 · CMS profile ID 113905

Allopathic & Osteopathic Physicians / Allergy & Immunology

ASHEVILLE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1508857319?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID MICHAEL CYPCAR, NPI 1508857319, CMS profile ID 113905. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508857319?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DAVID MICHAEL CYPCAR, NPI 1508857319, CMS profile ID 113905. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508857319?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DAVID MICHAEL CYPCAR, NPI 1508857319, CMS profile ID 113905, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1508857319?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $6,086.32 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–96 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Grifols USA, LLC $81.2106/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846779185 CMS
GlaxoSmithKline, LLC. $81.2006/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802130809 CMS
GlaxoSmithKline, LLC. $19.2806/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802213265 CMS
ALK-Abello, Inc $24.6306/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809203165 CMS
HOSPIRA, INC. $17.8906/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833281147 CMS
AstraZeneca Pharmaceuticals LP $20.1406/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834353071 CMS
Octapharma USA, Inc. $15.0506/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812973763 CMS
Pharming Healthcare, Inc. $21.6305/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820554441 CMS
AstraZeneca Pharmaceuticals LP $124.9905/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834329923 CMS
Genentech USA, Inc. $13.5705/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835902941 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.2305/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819903747 CMS
GlaxoSmithKline, LLC. $13.7505/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801606909 CMS
Optinose US, Inc. $15.9805/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851661479 CMS
GlaxoSmithKline, LLC. $4.8605/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801997265 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.1505/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819903743 CMS
AstraZeneca Pharmaceuticals LP $16.2105/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834350789 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.9305/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763652762 CMS
BioCryst US Sales Co., LLC $16.5204/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849107487 CMS
CSL Behring $19.9304/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820257753 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3.8804/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819903741 CMS
Teva Pharmaceuticals USA, Inc. $18.2004/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839470583 CMS
PFIZER INC. $13.2804/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832497595 CMS
Teva Pharmaceuticals USA, Inc. $11.8204/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839470579 CMS
PFIZER INC. $24.8704/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833282157 CMS
GlaxoSmithKline, LLC. $11.9004/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802011553 CMS
Teva Pharmaceuticals USA, Inc. $16.2303/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839470573 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.8103/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819903737 CMS
GlaxoSmithKline, LLC. $14.3303/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803020001 CMS
GlaxoSmithKline, LLC. $26.1103/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801606123 CMS
Optinose US, Inc. $2,000.0003/04/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851661603 CMS
PFIZER INC. $19.5803/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833282153 CMS
CSL Behring $21.2402/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820257699 CMS
GlaxoSmithKline, LLC. $14.7002/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802390455 CMS
GlaxoSmithKline, LLC. $12.7102/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802060995 CMS
ALK-Abello, Inc $19.0302/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809203161 CMS
Teva Pharmaceuticals USA, Inc. $11.7602/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839470569 CMS
GENZYME CORPORATION $23.1102/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843466481 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.0702/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819903735 CMS
AstraZeneca Pharmaceuticals LP $14.3702/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834332377 CMS
Teva Pharmaceuticals USA, Inc. $14.5302/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839470565 CMS
Optinose US, Inc. $17.1901/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851661429 CMS
Novartis Pharmaceuticals Corporation $14.9901/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812648993 CMS
BioCryst US Sales Co., LLC $16.5201/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849113267 CMS
GlaxoSmithKline, LLC. $30.8001/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803179903 CMS
CSL Behring $17.5201/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820257573 CMS
PFIZER INC. $17.3301/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832495485 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16,689.11 101
PY2020 $5,860.80 58
PY2021 $6,086.32 96
PY2022 $9,142.05 97
PY2023 $1,018.84 15
PY2024 $316.02 6
PY2025 $1,255.80 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $294,496.53 14
PY2024 Principal investigator $420,937.31 59
PY2023 Principal investigator $119,428.61 30
PY2022 Principal investigator $158,225.56 13
PY2021 Principal investigator $126,788.52 25
PY2020 Principal investigator $134,895.72 14
PY2019 Principal investigator $278,267.71 37

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 12/24/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184279976
Principal investigator 1 Novartis Pharmaceuticals Corporation $239.56 10/08/2025 Non-covered Recipient Entity
ALLERGY PARTNERS OF WEST NC
A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihista No dispute reported 06/30/2026 1190314133
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 08/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184232856
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 07/02/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184212371
Principal investigator 1 AstraZeneca Pharmaceuticals LP $179,419.72 07/01/2025 Non-covered Recipient Entity
ALLERGY PARTNERS, PA
ANCHOR No dispute reported 06/30/2026 1185538823
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $4,859.53 05/15/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040419
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 04/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190445
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 04/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190447
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $560.11 04/28/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190449
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $2,069.55 04/24/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040417
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $560.93 02/27/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040415
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $204.60 02/21/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PLLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040463
Principal investigator 1 AstraZeneca Pharmaceuticals LP $61,730.18 01/22/2025 Non-covered Recipient Entity
ALLERGY PARTNERS OF WESTERN NORTH CAROLINA
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod No dispute reported 06/30/2026 1185538821
Principal investigator 1 Eli Lilly and Company $42,051.80 01/21/2025 Non-covered Recipient Entity
ALLERGY PARTNERS PA
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB/ LY3650150 IN ADULT PARTICIPANTS WITH PERENNIAL ALLERGIC RHINITIS No dispute reported 06/30/2026 1187880527